信銘生命科技：中期報告202021.pdf

1、Aceso Life Science Group Limited 信銘生命科技集團有限公司1Interim Report 中期報告 2020/21CONTENTS 目錄Corporate Information2公司資料Management Discussion and Analysis5管理層討論及分析Disclosure of Interests22權益披露Corporate Governance27企業管治Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income29簡明綜合損益及其他

2、全面收益表Condensed Consolidated Statement of Financial Position31簡明綜合財務狀況報表Condensed Consolidated Statement of Changes in Equity34簡明綜合權益變動表Condensed Consolidated Statement of Cash Flows36簡明綜合現金流量表Notes to the Condensed Consolidated Financial Statements37簡明綜合財務報表附註2Interim Report 中期報告 2020/21CORPORATE IN

3、FORMATION公司資料Aceso Life Science Group Limited 信銘生命科技集團有限公司EXECUTIVE DIRECTORSMr.Xu HaiyingDr.Zhiliang Ou,J.P.(Australia)Mr.Fok Chi TakNON-EXECUTIVE DIRECTORSDr.Wang Yu(appointed on 18 August 2020)Dr.Li Yao(appointed on 18 August 2020)INDEPENDENT NON-EXECUTIVE DIRECTORSMr.Chan Ming Sun,JonathanMr.Lam

4、 Kwan SingMr.Lee Chi Hwa,JoshuaAUDIT COMMITTEEMr.Chan Ming Sun,Jonathan(Chairman of Committee)Mr.Lam Kwan SingMr.Lee Chi Hwa,JoshuaEXECUTIVE COMMITTEEMr.Xu HaiyingDr.Zhiliang Ou,J.P.(Australia)Mr.Fok Chi TakREMUNERATION COMMITTEEMr.Chan Ming Sun,Jonathan(Chairman of Committee)Dr.Zhiliang Ou,J.P.(Aus

5、tralia)Mr.Lam Kwan SingNOMINATION COMMITTEEDr.Zhiliang Ou,J.P.(Australia)(Chairman of Committee)Mr.Chan Ming Sun,JonathanMr.Lam Kwan Sing執行董事許海鷹先生歐志亮博士，太平紳士（澳洲）霍志德先生非執行董事王宇博士（於二零二零年八月十八日獲委任）李耀博士（於二零二零年八月十八日獲委任）獨立非執行董事陳銘燊先生林君誠先生李智華先生審核委員會陳銘燊先生（委員會主席）林君誠先生李智華先生執行委員會許海鷹先生歐志亮博士，太平紳士（澳洲）霍志德先生薪酬委員會陳銘燊先生（委

6、員會主席）歐志亮博士，太平紳士（澳洲）林君誠先生提名委員會歐志亮博士，太平紳士（澳洲）（委員會主席）陳銘燊先生林君誠先生3Interim Report 中期報告 2020/21CORPORATE INFORMATION公司資料Aceso Life Science Group Limited 信銘生命科技集團有限公司AUTHORISED REPRESENTATIVESMr.Fok Chi TakDr.Zhiliang Ou,J.P.(Australia)COMPANY SECRETARYMs.Chan Lai PingLEGAL ADVISERRaymond Siu&LawyersAUDITOR